North Brunswick, United States
Bionex Pharmaceuticals LLC is a company specializing in novel drug delivery and formulation design. The company is dedicated to applying bio-pharmaceutical and life sciences to create commercial products and services that benefit human health. Bionex engages in two primary areas of business activities. Firstly, the company offers contract R&D services, ranging from early-stage concept development to full-scale commercialization, for bio-pharmaceutical products. Additionally, Bionex develops and out-licenses its proprietary formulations, drug delivery technologies, and products related to medical, health food, and skin-care applications.
Bionex's expertise is centered on transdermal and transmucosal drug systems and the company prides itself on its science-based, pragmatic, and out-of-the-box approach. The company's capabilities include expertise in formulation science and analytical chemistry, a full range of formulation/processing, analytical, and testing capabilities in a cGMP facility, and a well-connected network of industrial, academic, and business consultants and advisors. Notably, many of Bionex's in-house innovation R&D projects are funded by National Institute of Health (NIH), National Science Foundation (NSF), state grants, and non-for-profit organizations.
Founded in 2007, Bionex operates in the Biotechnology, Health Care, Manufacturing, and Pharmaceutical industries. Although there is no available information on the company's current headquarters and last investment, Bionex Pharmaceuticals LLC presents promising prospects within the pharmaceutical and biotechnological sectors.
